However, a household name and consumer staples giant like Kimberly-Clark (NYSE: KMB) has the staying power to ride out the current environment and beyond. If it's a diversified healthcare business you're looking for, with a strong dividend history and a track record of delivering enviable balance sheet and shareholder returns, AbbVie fits the bill on all counts. Supply chain disruptions and inflation have weighed on Kimberly-Clark's margins and bottom line in recent financial reports, but it has nonetheless continued to generate consistent revenue growth and profitability.